# OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study

> **NCT01643772** · PHASE1 · COMPLETED · sponsor: **Mundipharma (China) Pharmaceutical Co. Ltd** · enrollment: 61 (actual)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Oxycodone hydrochloride

## Key facts

- **NCT ID:** NCT01643772
- **Lead sponsor:** Mundipharma (China) Pharmaceutical Co. Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2019-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01643772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01643772, "OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01643772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*